NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Vaaji Smart Patch Pilot Study on Medication Error Prevention
TL;DR
Vaaji's smart patch system offers a competitive edge by preventing medication errors, potentially reducing healthcare costs and improving patient outcomes in transdermal drug delivery.
Vaaji's system uses IoT sensors and AI to monitor patch status with 100% accuracy, detecting stacking errors in real-time through a validated proof-of-concept study.
This technology enhances patient safety for conditions like Alzheimer's, reducing overdose risks and supporting independent living for aging populations through smarter home care.
A smart patch system achieved perfect accuracy in detecting medication errors, using AI to transform standard patches into intelligent safety tools for healthcare.
Found this article helpful?
Share it with your network and spread the knowledge!
Vaaji announced the successful completion of a pilot study that achieved 100% technical accuracy in monitoring patch status, validating their smart patch system as a tool to improve safety in transdermal drug delivery.
It addresses critical safety gaps where patients or caregivers may accidentally apply multiple patches (patch stacking) or forget applications entirely, which can lead to ineffective treatment or potentially life-threatening overdoses in conditions like Alzheimer's, Parkinson's, and pain management.
The system transforms standard passive patches into 'smart' therapeutics by leveraging advanced Internet of Things (IoT) sensors and Artificial Intelligence to provide real-time visibility into medication adherence and detect errors like patch stacking.
The study achieved 100% agreement between remote monitoring data and site investigator records, successfully identified simulated patch stacking in real-time, and validated that the technology integrated smoothly into volunteers' daily routines for home-based care feasibility.
Vaaji conducted the study in collaboration with the Penn Artificial Intelligence and Technology Collaboratory (PennAITech) at the University of Pennsylvania, with 51 healthy volunteers using placebo patches, and it was part of the AI/Tech + Aging (A2) Collective funded by the National Institute on Aging (NIA).
The smart patch system is designed for transdermal drug delivery for medications treating Alzheimer's (such as rivastigmine), Parkinson's, and pain management.
The data from this pilot study will inform Vaaji's clinical and regulatory strategy as the company advances toward broader clinical trials involving active therapeutics.
Patrick Mercier, Professor of Electrical and Computer Engineering at UCSD and Chief Technical Advisor at Vaaji, William Z. Potter, MD, PhD, co-Principal Investigator and Chief Scientific Advisor at Vaaji, and Sandeep Patil, MD, PhD, Co-founder of Vaaji all provided statements about the significance of the findings.
Curated from 24-7 Press Release
